1. Home
  2. KYMR vs HWKN Comparison

KYMR vs HWKN Comparison

Compare KYMR & HWKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • HWKN
  • Stock Information
  • Founded
  • KYMR 2015
  • HWKN 1938
  • Country
  • KYMR United States
  • HWKN United States
  • Employees
  • KYMR N/A
  • HWKN N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • HWKN Specialty Chemicals
  • Sector
  • KYMR Health Care
  • HWKN Consumer Discretionary
  • Exchange
  • KYMR Nasdaq
  • HWKN Nasdaq
  • Market Cap
  • KYMR 4.2B
  • HWKN 3.6B
  • IPO Year
  • KYMR 2020
  • HWKN N/A
  • Fundamental
  • Price
  • KYMR $56.83
  • HWKN $176.77
  • Analyst Decision
  • KYMR Strong Buy
  • HWKN Buy
  • Analyst Count
  • KYMR 17
  • HWKN 2
  • Target Price
  • KYMR $61.65
  • HWKN $200.00
  • AVG Volume (30 Days)
  • KYMR 910.5K
  • HWKN 139.4K
  • Earning Date
  • KYMR 10-30-2025
  • HWKN 10-29-2025
  • Dividend Yield
  • KYMR N/A
  • HWKN 0.43%
  • EPS Growth
  • KYMR N/A
  • HWKN 5.20
  • EPS
  • KYMR N/A
  • HWKN 4.05
  • Revenue
  • KYMR $44,711,000.00
  • HWKN $1,011,824,000.00
  • Revenue This Year
  • KYMR $62.11
  • HWKN $15.55
  • Revenue Next Year
  • KYMR N/A
  • HWKN $6.31
  • P/E Ratio
  • KYMR N/A
  • HWKN $43.70
  • Revenue Growth
  • KYMR N/A
  • HWKN 9.51
  • 52 Week Low
  • KYMR $19.45
  • HWKN $98.30
  • 52 Week High
  • KYMR $59.00
  • HWKN $186.15
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 65.68
  • HWKN 52.64
  • Support Level
  • KYMR $54.09
  • HWKN $175.21
  • Resistance Level
  • KYMR $59.00
  • HWKN $186.15
  • Average True Range (ATR)
  • KYMR 2.39
  • HWKN 5.48
  • MACD
  • KYMR 0.30
  • HWKN 0.37
  • Stochastic Oscillator
  • KYMR 80.00
  • HWKN 50.69

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About HWKN Hawkins Inc.

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.

Share on Social Networks: